Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Long Term Safety of the Use of Dabigatran Etexilate in Patients With a Bileaflet Mechanical Heart Valve

NCT01505881 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT01505881
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01505881 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Long Term Safety of the Use of Dabigatran Etexilate in Patients With a Bileaflet Mechanical Heart Valve
Lead sponsor
Boehringer Ingelheim
Phase
Phase 2
Overall status
Terminated
Start date
December 31, 2011
Completion date
June 30, 2013
Enrollment
158 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

heart valve prosthesis, thromboembolism